JG
SANA icon

Jain Global’s Sana Biotechnology SANA Stock Holding History

Jain Global’s Portfolio SANA Stock Details SANA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-32,227
Closed -$114K – 1479
2025
Q3 		$114K Sell
32,227
-16,926
-34% -$61.2K ﹤0.01% 934
2025
Q2 		$134K Sell
49,153
-3,450
-7% -$7.12K ﹤0.01% 1011
2025
Q1 		$88.4K Sell
52,603
-2,854
-5% -$7.98K ﹤0.01% 975
2024
Q4 		$90.4K Buy
+55,457
New +$165K ﹤0.01% 692

Other funds holding SANA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
MG
Marex Group London $15.8B AUM 31.44% 1-Year Est. Return
IHAM
Integral Health Asset Management New York $2.09B AUM 112.84% 1-Year Est. Return

Jain Global's SANA Position: Q4 2025 in Review

Jain Global sold out of Sana Biotechnology (SANA) in Q4 2025, closing a stake of 32,227 shares — an estimated $114K sold.

Jain Global first reported a position in SANA in Q4 2024 and held it in 4 quarters. The position peaked at $134K in Q2 2025. 203 funds tracked by Wall St. Rank hold SANA as of Q4 2025.

  • Jain Global reported no remaining Sana Biotechnology position as of Q4 2025 after selling out during the quarter.
  • Jain Global sold 32,227 Sana Biotechnology shares in Q4 2025, an estimated $114K.
  • Jain Global first reported a position in Sana Biotechnology in Q4 2024 and held it in 4 quarters.
  • Jain Global's Sana Biotechnology position peaked at $134K in Q2 2025.
  • 203 funds tracked by Wall St. Rank held Sana Biotechnology as of Q4 2025.

Based on Jain Global's 13F filing for Q4 2025, filed 17 Feb 2026.